SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

UK blocks Israeli Defense Ministry from London arms fair over Gaza war

“This is our AI advantage”: SentinelOne CEO hails AI edge amid earnings jump and Prompt acquisition

Global AI rankings: ChatGPT on top, Gemini and Perplexity catching up

Rafael CEO backs IPO plans, says hypersonic missile interceptor in advanced development

More stories 24more

24more

Buzz

Most popular

Daily

Weekly

1

Cyber unicorn Cato Networks in advanced talks to acquire Aim Security for $350-400 million

2

As EU weighs limits on Israeli research, Poland offers support to Startup Nation

3

Okta acquires Israeli cyber startup Axiom in $100 million deal

4

Nvidia’s Israeli network: The $7 billion bet that built a $30 billion business

5

"I achieved the Holy Grail: I built software that builds software"

Buzzmore

Epitomee

4 stories about Epitomee

גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki

Investors are hopeful, but the company must now face an uphill battle in a crowded market.

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki

The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway

Weight-Loss Pill Developer Epitomee Raises $8 Million

Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full